AIDS is a syndrome caused by the HIV virus. It is when a person’s immune system is too weak to fight off many infections, and develops when the HIV infection is very advanced. This is the last stage of HIV infection where the body can no longer defend itself and may develop various diseases, infections and if left untreated, death. There is currently no cure for HIV or AIDS. However, with the right treatment and support, people can live long and healthy lives with HIV.
1. It may cause influenza-like illness, tuberculosis, opportunistic infections and tumors, pneumocystis pneumonia, severe weight loss, Kaposi's sarcoma. The time period usually ranges from 6 months (rarely) to 15+ years. HIV infection passes through a series of steps or stages before it turns into AIDS. These stages of infection as outlined in 1993 by the Centers for Disease Control. Seroconversion illness – this occurs in 1 to 6 weeks after acquiring the infection. The feeling is similar to a bout of flu.
2. Asymptomatic infection – After seroconversion, virus levels are low and replication continues slowly. CD4 and CD8 lymphocyte levels are normal. This stage has no symptoms and may persist for years together.
3. Persistent generalised lymphadenopathy (PGL) – The lymph nodes in these patients are swollen for three months or longer and not due to any other cause.
4. Symptomatic infection – This stage manifests with symptoms. In addition, there may be opportunistic infections. This collection of symptoms and signs is referred to as the AIDS-related complex (ARC) and is regarded as a prodrome or precursor to AIDS.
1115 new HIV diagnoses in 2013, Decline of 9% as compared to 2012 Belgium had a total of 24,506 HIV cases by the end of 2011. Out of the total, 4,181 developed AIDS. For the year of 2011 alone, there were 1,177 new HIV cases, 54 new AIDS cases, and 30 HIV-related deaths found. Most of the newly diagnosed cases were transmitted through heterosexual contact, 49.6%. Secondly, HIV cases transmitted through sexual contact among men were at 46.6%. Third, 1.3% of HIV cases were transmitted through injected drug use. And 1.0% of HIV cases were transmitted from mother to child. The relatively high rate of baseline resistance might jeopardize the success of first line treatment as more than 1 out of 10 (30/285, 10.5%) viruses did not score as fully susceptible to one of the recommended first-line regimens, i.e., zidovudine, lamivudine, and efavirenz.
This early-release guideline makes available two key recommendations that were developed during the revision process in 2015. First, antiretroviral therapy (ART) should be initiated in everyone living with HIV at any CD4 cell count. Second, the use of daily oral pre-exposure prophylaxis (PrEP) is recommended as a prevention choice for people at substantial risk of HIV infection as part of combination prevention approaches. Belgium has taken a substantial step forward in its AIDS response this week with the launch of its first and much-anticipated National Strategic Plan on HIV.belgium has become the second country after the United States where people at high risk can take drugs that restrict their chances of contracting HIV.The treatment, called pre-exposure prophylaxis (PrEP), consists of taking one pill every day. It’s meant for people who are at substantial risk of contracting HIV, such as partners of HIV-positive patients.